These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 1548069)

  • 1. Tumor necrosis factor production in patients with leprosy.
    Barnes PF; Chatterjee D; Brennan PJ; Rea TH; Modlin RL
    Infect Immun; 1992 Apr; 60(4):1441-6. PubMed ID: 1548069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL).
    Sampaio EP; Moraes MO; Nery JA; Santos AR; Matos HC; Sarno EN
    Clin Exp Immunol; 1998 Feb; 111(2):300-8. PubMed ID: 9486396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro tumor necrosis factor production by mononuclear cells from lepromatous leprosy patients and from patients with erythema nodosum leprosum.
    Santos DO; Suffys PN; Bonifácio K; Marques MA; Sarno EN
    Clin Immunol Immunopathol; 1993 Jun; 67(3 Pt 1):199-203. PubMed ID: 8500267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological cytokine correlates of protective immunity and pathogenesis in leprosy.
    Lima MC; Pereira GM; Rumjanek FD; Gomes HM; Duppre N; Sampaio EP; Alvim IM; Nery JA; Sarno EN; Pessolani MC
    Scand J Immunol; 2000 Apr; 51(4):419-28. PubMed ID: 10736116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of transforming growth factor-beta 1 (TGF-beta1) by blood monocytes from patients with different clinical forms of leprosy.
    Goulart IM; Mineo JR; Foss NT
    Clin Exp Immunol; 2000 Dec; 122(3):330-4. PubMed ID: 11122237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
    J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lsr2 of Mycobacterium leprae and its synthetic peptides elicit restitution of T cell responses in erythema nodosum leprosum and reversal reactions in patients with lepromatous leprosy.
    Saini C; Prasad HK; Rani R; Murtaza A; Misra N; Shanker Narayan NP; Nath I
    Clin Vaccine Immunol; 2013 May; 20(5):673-82. PubMed ID: 23446220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low serum HDL-cholesterol is associated with raised tumor necrosis factor-alpha during ENL reactions.
    Memon RA; Kifayet A; Shahid F; Lateef A; Chiang J; Hussain R
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):1-11. PubMed ID: 9207748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological status of ENL (erythema nodosum leprosum) patients: its relationship to bacterial load and levels of circulating IL-2R.
    Vieira LM; Sampaio EP; Nery JA; Duppre NC; Albuquerque EC; Scheinberg MA; Sarno EN
    Rev Inst Med Trop Sao Paulo; 1996; 38(2):103-11. PubMed ID: 9071029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sera of leprosy patients with type 2 reactions recognize selective sequences in Mycobacterium leprae recombinant LSR protein.
    Singh S; Narayanan NP; Jenner PJ; Ramu G; Colston MJ; Prasad HK; Nath I
    Infect Immun; 1994 Jan; 62(1):86-90. PubMed ID: 7505263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory T cells in erythema nodosum leprosum maintain anti-inflammatory function.
    Negera E; Bobosha K; Aseffa A; Dockrell HM; Lockwood DNJ; Walker SL
    PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010641. PubMed ID: 35867720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG antibody subclasses, tumor necrosis factor and IFN-gamma levels in patients with type II lepra reaction on thalidomide treatment.
    Partida-Sanchez S; Favila-Castillo L; Pedraza-Sanchez S; Gomez-Melgar M; Saul A; Estrada-Parra S; Estrada-Garcia I
    Int Arch Allergy Immunol; 1998 May; 116(1):60-6. PubMed ID: 9623511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterial carbohydrate antigens for serological testing of patients with leprosy.
    Levis WR; Meeker HC; Schuller-Levis G; Sersen E; Brennan PJ; Fried P
    J Infect Dis; 1987 Nov; 156(5):763-9. PubMed ID: 3116103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effects of Prednisolone Treatment on Cytokine Expression in Patients with Erythema Nodosum Leprosum Reactions.
    Negera E; Walker SL; Bobosha K; Bekele Y; Endale B; Tarekegn A; Abebe M; Aseffa A; Dockrell HM; Lockwood DN
    Front Immunol; 2018; 9():189. PubMed ID: 29479352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential interferon- gamma production characterizes the cytokine responses to Leishmania and Mycobacterium leprae antigens in concomitant mucocutaneous leishmaniasis and lepromatous leprosy.
    Matos DS; Azeredo-Coutinho RB; Schubach A; Conceição-Silva F; Baptista C; Moreira JS; Mendonça SC
    Clin Infect Dis; 2005 Jan; 40(2):e5-12. PubMed ID: 15655736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythema Nodosum Leprosum Neutrophil Subset Expressing IL-10R1 Transmigrates into Skin Lesions and Responds to IL-10.
    Pacheco FS; Prata RBDS; Brandão SS; Ferreira H; Rodrigues TF; Brandão Dos Santos J; da Silva CO; Tavares IF; Mendes MA; Rodrigues ACDP; Machado AM; Nery JADC; Amadeu TP; Moraes MO; Sarno EN; Schmitz V
    Immunohorizons; 2020 Feb; 4(2):47-56. PubMed ID: 32034084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential immunoglobulin and complement levels in leprosy prior to development of reversal reaction and erythema nodosum leprosum.
    Amorim FM; Nobre ML; Nascimento LS; Miranda AM; Monteiro GRG; Freire-Neto FP; Queiroz MDCP; Queiroz JW; Duthie MS; Costa MR; Reed SG; Johnson WD; Dupnik KM; Jeronimo SMB
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007089. PubMed ID: 30689631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalidomide in the treatment of leprosy.
    Teo S; Resztak KE; Scheffler MA; Kook KA; Zeldis JB; Stirling DI; Thomas SD
    Microbes Infect; 2002 Sep; 4(11):1193-202. PubMed ID: 12361920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgM and IgG antibodies to phenolic glycolipid I from Mycobacterium leprae in leprosy: insight into patient monitoring, erythema nodosum leprosum, and bacillary persistence.
    Levis WR; Meeker HC; Schuller-Levis G; Sersen E; Schwerer B
    J Invest Dermatol; 1986 May; 86(5):529-34. PubMed ID: 3528312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between TNF production, increase of plasma C-reactive protein level and suppression of T lymphocyte response to concanavalin A during erythema nodosum leprosum.
    Foss NT; de Oliveira EB; Silva CL
    Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):218-26. PubMed ID: 8371031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.